NYSE:GSK - GlaxoSmithKline Stock Price, Price Target & More

GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

GlaxoSmithKline announced a quarterly dividend on Thursday, April 26th. Investors of record on Friday, May 11th will be paid a dividend of $0.5298 per share on Thursday, July 12th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 5.06%. The ex-dividend date is Thursday, May 10th. View GlaxoSmithKline's Dividend History.

GlaxoSmithKline plc (NYSE:GSK) released its quarterly earnings data on Wednesday, April, 25th. The pharmaceutical company reported $0.68 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.70 by $0.02. The pharmaceutical company earned $10.04 billion during the quarter, compared to the consensus estimate of $10.26 billion. GlaxoSmithKline had a return on equity of 144.84% and a net margin of 3.50%. View GlaxoSmithKline's Earnings History.

GlaxoSmithKline is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for GlaxoSmithKline.

13 brokers have issued 1-year price objectives for GlaxoSmithKline's shares. Their forecasts range from $35.85 to $40.00. On average, they expect GlaxoSmithKline's stock price to reach $38.6167 in the next year. This suggests that the stock has a possible downside of 7.8%. View Analyst Ratings for GlaxoSmithKline.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to GlaxoSmithKline include Johnson & Johnson (JNJ), Pfizer (PFE), Novartis (NVS), Merck & Co., Inc. (MRK), AbbVie (ABBV), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT), Sanofi (SNY), Eli Lilly And Co (LLY), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG), Allergan (AGN) and Shire (SHPG).

News stories about GSK stock have trended somewhat positive recently, according to Accern Sentiment. The research firm rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. GlaxoSmithKline earned a media sentiment score of 0.12 on Accern's scale. They also gave media headlines about the pharmaceutical company an impact score of 45.84 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

GlaxoSmithKline's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (0.56%), Confluence Investment Management LLC (0.06%), Cornerstone Wealth Management LLC (0.01%), Bank of Montreal Can (0.01%), Farmers Trust Co. (0.00%) and Creative Planning (0.00%). View Institutional Ownership Trends for GlaxoSmithKline.

GSK stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Miller Howard Investments Inc. NY, World Asset Management Inc, Farmers Trust Co., Atria Investments LLC, Benjamin F. Edwards & Company Inc., Park National Corp OH and Bank of Montreal Can. View Insider Buying and Selling for GlaxoSmithKline.

GSK stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Cornerstone Wealth Management LLC, Chemung Canal Trust Co., Ipswich Investment Management Co. Inc., Guardian Investment Management, First Financial Bank Trust Division, Ballentine Partners LLC and First Citizens Bank & Trust Co.. View Insider Buying and Selling for GlaxoSmithKline.

Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of GSK stock can currently be purchased for approximately $41.87.

GlaxoSmithKline has a market capitalization of $100.89 billion and generates $38.89 billion in revenue each year. The pharmaceutical company earns $1.97 billion in net income (profit) each year or $2.88 on an earnings per share basis. GlaxoSmithKline employs 99,827 workers across the globe.

GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD MIDDLESEX X0, TW8 9GS. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]